Curie Therapeutics collects $75M to develop ... - PitchBook

Curie Therapeutics Collects $75M To Develop ... - PitchBook

2 weeks from now

Dec 2, 2021  · Biotech startup Curie Therapeutics has emerged from stealth and raised a $75 million Series A. The company is developing radiopharmaceuticals designed to target solid …

pitchbook.com

Curie Therapeutics Raises $75 Million Financing To Further Its …

2 weeks from now

CAMBRIDGE, Mass., Dec. 1, 2021 /PRNewswire/ -- Curie Therapeutics Inc. ("Curie"), a biotechnology company incubated by Atlas Ventures, Access Biotechnology and RA Capital …

firstwordpharma.com

Curie Therapeutics Raises $75M To Change Cancer Care Forever

2 weeks from now

Dec 4, 2021  · Curie Therapeutics, a biotechnology startup based in Boston, has raised $75 million in Series A funding to develop precision radiopharmaceuticals that change how solid tumors …

gritdaily.com

Curie Therapeutics Comes Out Of Stealth With $75m

2 weeks from now

US-based radiation oncology treatment developer Curie Therapeutics emerged from stealth yesterday with $75m in series A funding from investors including Access Biotechnology, a …

globalventuring.com

Curie Therapeutics Raises $75 Million Financing To Further

2 weeks from now

Dec 1, 2021  · About Curie Therapeutics. Curie Therapeutics is a fully integrated, next-generation radiopharmaceuticals company focused on pioneering a new class of targeted …

biospace.com

Curie Therapeutics Unveils $75M To Widen Scope Of …

2 weeks from now

Dec 1, 2021  · Radiopharmaceuticals deploy radiation to damage cancer DNA, but Curie Therapeutics sees these therapies opening the door to a wider range of ways to kill tumors. …

medcitynews.com

VC Daily: Curie Therapeutics Grabs $75 Million To Develop ...

2 weeks from now

Dec 2, 2021  · Curie Therapeutics Inc. has raised $75 million in Series A financing to develop radiopharmaceutical treatments for cancer, a sign of the growing interest investors are …

wsj.com

Curie Therapeutics Lines Up $75M To Tackle Radiopharmaceuticals …

2 weeks from now

Dec 6, 2021  · We now know what some of Ra Pharmaceuticals’ former executives have been up to since UCB acquired the biotech for $2.5 billion. Simon Read, Ph.D., and Alonso Ricardo, …

biotech-today.com

Curie Therapeutics Raises $75 Million Financing To Further Its …

2 weeks from now

Dec 2, 2021  · CAMBRIDGE, MA, USA I December 1, 2021 I Curie Therapeutics Inc. (“Curie”), a biotechnology company incubated by Atlas Ventures, Access Biotechnology and RA Capital …

pipelinereview.com

Curie Therapeutics Raises $75M Series A - Vcnewsdaily.com

2 weeks from now

Dec 1, 2021  · Curie Therapeutics, a biotechnology company incubated by Atlas Ventures, Access Biotechnology and RA Capital Management, announced a Series A investment of $75 million …

vcnewsdaily.com

Curie Therapeutics Comes Out Of Stealth With $75m - Global …

2 weeks from now

Dec 2, 2021  · Curie Therapeutics comes out of stealth with $75m ... US-based radiation oncology treatment developer Curie Therapeutics emerged from stealth yesterday with $75m in series A …

globalventuring.com

Curie Therapeutics Raises $75 Million Financing To Further Its …

2 weeks from now

On December 1, 2021 Curie Therapeutics Inc. ("Curie"), a biotechnology company incubated by Atlas Ventures, Access Biotechnology and RA Capital Management, reported a Series A …

1stoncology.com

Curie Therapeutics Raises $75 Million Series A - Citybiz

2 weeks from now

Dec 1, 2021  · Curie Therapeutics Inc., a biotechnology company incubated by Atlas Ventures, Access Biotechnology and RA Capital Management, today announced a Series A investment …

citybiz.co

Differentiated Therapeutics Picks Up $5M - PitchBook

2 weeks from now

Aug 2, 2022  · The company uses molecular simulation to develop disease-modifying therapies. Differentiated Therapeutics has raised $5 million in seed funding from Curie.Bio. The company …

pitchbook.com